Calidi Biotherapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

2.66M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	45.00K	-404.00K	-89.98%
Dec 31, 2021	449.00K	-	-
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SciSparc	856.00K
Onconetix	735.20K
VivoSim Labs	142.00K
Virax Biolabs Group	12.42K
Azitra	7.50K
Creative Medical Technology Holdings	3.00K

Revenue Rankings

CLDI News

4 days ago - Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
19 days ago - Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit - GlobeNewsWire
20 days ago - Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors - GlobeNewsWire
27 days ago - Calidi receives pre-IND regulatory feedback from FDA for CLD-401 - TheFly
27 days ago - Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study - GlobeNewsWire
5 weeks ago - Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026 - GlobeNewsWire
6 weeks ago - Calidi announces online abstract acceptances at 2026 ASCO Meeting - TheFly
6 weeks ago - Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting - GlobeNewsWire

More News